Mounjaro and stomach ulcers: what you need to discuss with a prescriber

Step 1 — Understand what Mounjaro does to the stomach

Mounjaro (tirzepatide) activates two gut-hormone receptors, GIP and GLP-1, and one of its direct effects is slowing the rate at which the stomach empties food into the small intestine. That is part of how it reduces appetite and blunts post-meal blood-sugar spikes. For most people it is tolerable. For someone with an active stomach ulcer, though, that delay in gastric emptying can increase the time that stomach acid and digestive contents sit in contact with already-damaged tissue. That is the core concern, and it is why upper GI conditions appear in the prescribing considerations for this class of medicines.

The NHS medicines page for tirzepatide notes that gastrointestinal symptoms are among the most commonly reported effects, particularly at the start of treatment or after a dose increase. Nausea, vomiting, stomach pain and reflux all feature. The practical problem for someone with a stomach ulcer is that these symptoms can look identical to a worsening ulcer, which makes monitoring harder.

This is not a theoretical risk invented to put people off. It reflects how the medicine interacts with gut motility, and it is the same reason people are asked on their Mounjaro consultation form whether they have any significant gastrointestinal conditions.

Step 2 — Disclose your full history clearly in your consultation

Honesty in the consultation form is not a formality. If you have had a peptic ulcer, say so, and include the detail that matters: whether it was confirmed on endoscopy, whether it was caused by H. pylori infection, whether it has been fully treated and cleared, and whether you currently take a proton-pump inhibitor (PPI) or antacid. A healed, H. pylori-negative ulcer confirmed clear by a GP or gastroenterologist is a very different situation from one that is active, symptomatic and not yet under control.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the same day it is submitted. Your answers are not filtered by software before they reach a clinician. If your history raises a question, the prescriber may ask for more detail or may recommend you discuss the matter further with your GP or gastroenterologist before treatment begins. That is not a rejection; it is exactly what clinical oversight is for.

People sometimes feel deflated when they are asked to pause and gather more information, particularly if they have been waiting to start treatment. That frustration is understandable. The reason the process exists is to protect you, not to create friction.

Step 3, Understand what the evidence and guidance actually say

There is no absolute contraindication to tirzepatide in people who have a history of stomach ulcers that is fully healed and stable. The SmPC and the BNF entry for tirzepatide categorise severe gastrointestinal disease as a caution, not a blanket prohibition. A prescriber's job is to weigh the degree of your GI history against the clinical benefit of treatment for you specifically.

Where an ulcer is active, bleeding, or only recently treated, the picture is different. Starting a medicine that slows gastric emptying and commonly causes nausea and stomach pain while an ulcer is healing is unlikely to be appropriate. The prescriber will reach that conclusion, and it stands.

If your ulcer history is documented and settled, and you are otherwise a good candidate for weight management treatment, a prescriber can make an informed call. The question of whether Mounjaro can itself cause stomach ulcers is a related but separate topic, and one worth reading if it is part of your concern. There is also useful context on taking Mounjaro with GERD for anyone managing acid reflux alongside a peptic history.

Step 4, Know which symptoms need urgent attention

If you do begin Mounjaro and develop severe or worsening stomach pain, particularly pain that spreads to your back, do not assume it is a routine GI side effect. The MHRA issued specific guidance in January 2026 flagging acute pancreatitis as a known but infrequent serious effect of GLP-1 class medicines: the key symptom is severe, persistent abdominal pain that may radiate to the back, with or without vomiting. That needs urgent medical assessment, not a wait-and-see approach.

Separately, stomach pain in someone with a ulcer history could indicate ulcer recurrence or complication, and if you want to understand the full range of oral and digestive symptoms that can occur, our guide to Mounjaro mouth ulcers covers how tirzepatide can affect the mouth and wider digestive tract. Either way, persistent severe abdominal pain is a reason to seek medical help promptly, not to manage at home. You can also report suspected side effects through the MHRA's Yellow Card scheme, which helps the regulator track patterns across the population.

On a practical note, some people with upper GI sensitivity find that the timing of their injection relative to meals affects their tolerance. That is a detail best discussed with your prescriber once you have started treatment. Similarly, if you also have IBS alongside your ulcer history, it is worth mentioning both in your consultation. For a broader overview of how the treatment works and what to expect, the weight-loss treatment overview sets out the full picture in plain terms.

If you are ready to have your situation reviewed by a prescriber, speak to our prescribers via a free consultation and disclose your GI history in full. That is the only way to get an answer that is specific to you.